ArticleNeurologia medico-chirurgica2026
Prognostic Impact of Calcification, Corpus Callosum Invasion, and CDKN2A/B Hemizygous Deletion in Oligodendroglioma: A Single-center Retrospective Study.
Article in Neurologia medico-chirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oligodendrogliomas generally have a better prognosis than other adult-type diffuse gliomas. However, although several clinical and radiological prognostic factors have been reported, long-term outcomes remain heterogeneous, and decisions regarding postoperative treatment remain challenging because of concerns about long-term adverse effects. This study aimed to explore prognostic factors by analyzing clinical, radiological, therapeutic, and genetic data from a single-institution cohort.We retrospectively reviewed adult patients (≥18 years) with isocitrate dehydrogenase-mutant and 1p/19q-codeleted oligodendrogliomas who underwent surgical resection at our institution between 1999 and 2021, with available preoperative magnetic resonance imaging and computed tomography. CDKN2A/B copy number status was assessed using multiplex ligation-dependent probe amplification and confirmed by fluorescence in situ hybridization. Overall survival and progression-free survival were analyzed using the Kaplan-Meier method and Cox proportional hazards models. For overall survival, simple multivariable Cox models adjusted for age and Karnofsky Performance Status were constructed.A total of 32 patients were included. The median age was 40 years, and the median Karnofsky Performance Status was 90. Calcification and corpus callosum invasion were observed in 46.9% and 40.6% of cases, respectively, and CDKN2A/B hemizygous deletion was identified in four cases. The 5-year progression-free survival was 62.0%, and the 5-year overall survival was 86.5%. On univariable Cox analysis for overall survival, corpus callosum invasion, calcification, and CDKN2A/B hemizygous deletion were significant adverse prognostic factors. In simple multivariable Cox models, CDKN2A/B hemizygous deletion remained associated with shorter overall survival.Calcification, corpus callosum invasion, and CDKN2A/B hemizygous deletion may be prognostic markers in oligodendroglioma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.